Home
About
Overview
Sharing Data
ORCID
Help
History (107)
Fractional Flow Reserve, Myocardial
Cricetulus
Down-Regulation
Potential contribution of ryanodine receptor 2 upregulation to cGMP/PKG signaling-induced cone degeneration in cyclic nucleotide-gated channel deficiency.
Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy.
See All 107 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy.
Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy. J Urol. 2011 Apr; 185(4):1478-83.
View in:
PubMed
subject areas
Administration, Intravesical
Animals
Antineoplastic Agents, Phytogenic
Carcinoma, Transitional Cell
Dogs
Drug Delivery Systems
Gelatin
Humans
Nanoparticles
Paclitaxel
Tumor Cells, Cultured
Urinary Bladder Neoplasms